CTMX CytomX Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$2,56
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,5552-Wochen-Tief
$8,2152-Wochen-Hoch
Marktkapitalisierung
$436M
Umsatz
$76M
Ihre Abzeichen
52W-Spanne
$3–$8
Analystenbewertung
BUY
Kursziel
$12
P/E
·
ROE
-15.9%
Nettogewinnmarge
-435.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CTMX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.56
Marktkapitalisierung
$436M
Umsatz
$76M
ROE
-15.9%
52W-Spanne
$3–$8
CTMX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$76M2016-12-31 → 2025-12-31
Freier Cashflow$-76M2018-12-31 → 2025-12-31
Nettogewinnmarge-435.2%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CTMX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/S | 5.75-Jahres-Durchschnitt ≈3.3 | ≈3.3 | 125.6 | Unterbewertet | |
| P/B (K/B) | 4.45-Jahres-Durchschnitt ≈-44.3 | ≈-44.3 | 2.7 | Überbewertet | |
| Price / FCF (Kurs / FCF) | -5.75-Jahres-Durchschnitt ≈-3.3 | ≈-3.3 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -5.85-Jahres-Durchschnitt ≈-3.3 | ≈-3.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 4.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CTMX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -476.2%5-Jahres-Durchschnitt ≈-52.1% | ≈-52.1% | -2083.6% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -29.3%5-Jahres-Durchschnitt ≈-52.1% | ≈-52.1% | -2083.6% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -433.9%5-Jahres-Durchschnitt ≈-45.7% | ≈-45.7% | -1976.9% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -435.2%5-Jahres-Durchschnitt ≈-46.8% | ≈-46.8% | -1978.2% | Spitzenklasse | |
| ROA | -12.8%5-Jahres-Durchschnitt ≈-6.6% | ≈-6.6% | -38.2% | Spitzenklasse | |
| ROE | -15.9%5-Jahres-Durchschnitt ≈-40.5% | ≈-40.5% | -43.9% | Spitzenklasse | |
| ROIC | -22.9%5-Jahres-Durchschnitt ≈-1337.5% | ≈-1337.5% | -39.0% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CTMX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 9.45-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 10.7 | Geringe Liquidität | |
| Quick Ratio | 0.35-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 7.5 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CTMX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -44.8%5-Jahres-Durchschnitt ≈15.8% | ≈15.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 12.8%5-Jahres-Durchschnitt ≈27.1% | ≈27.1% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 2.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CTMX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 29.85-Jahres-Durchschnitt ≈20.0 | ≈20.0 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.1M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2.1%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.09 | $-0.08 | -13.8% |
| 31. März 2026 | Mai 11, 2026 | $-0.10 | $-0.12 | 18.8% |
| 31. Dezember 2025 | $-0.22 | $-0.10 | -130.4% | |
| 30. September 2025 | $-0.09 | $-0.05 | -74.4% | |
| 30. Juni 2025 | $-0.00 | $-0.08 | 98.7% | |
| 31. März 2025 | $0.27 | $0.13 | 113.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76M | $138M | $101M | $53M | $37M | $68M | $27M | $60M | $72M | $15M | $8M | $5M | |
| R&D Expense | $69M | $83M | $78M | $112M | $114M | $113M | $132M | $104M | $92M | $55M | $28M | $28M | |
| SG&A Expense | $30M | $30M | $30M | $43M | $39M | $36M | $37M | $34M | $26M | $20M | $13M | $7M | |
| Operating Expenses | $99M | $113M | $108M | $154M | $153M | $149M | $168M | $137M | $118M | $75M | $41M | $35M | |
| Operating Income | $-22M | $25M | $-6M | $-101M | $-116M | $-81M | $-141M | $-78M | $-46M | $-60M | $-33M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | $2M | $487.0K | |
| Interest Income | $5M | $7M | $10M | $2M | $255.0K | $2M | $8M | $8M | $3M | $736.0K | $1M | $7.0K | |
| Other Non-op | $28.0K | $-38.0K | $-30.0K | $340.0K | $-83.0K | $-27.0K | $-135.0K | $-68.0K | $-27.0K | $-69.0K | $-2M | $-55.0K | |
| Pretax Income | $-17M | $32M | $3M | $-99M | $-116M | $-79M | $-133M | $-70M | $-44M | $-59M | $-35M | $-30M | |
| Income Tax | $238.0K | $224.0K | $4M | $0 | $0 | $-14M | $-427.0K | $14M | $-513.0K | $-19.0K | $10.0K | $10.0K | |
| Net Income | $-17M | $32M | $-569.0K | $-99M | $-116M | $-65M | $-133M | $-85M | $-43M | $-59M | $-35M | $-30M | |
| Shares (Basic) | 137,935,873 | 84,439,303 | 73,808,237 | 65,739,844 | 64,146,848 | 46,145,563 | 45,335,927 | · | · | · | · | · | |
| Shares (Diluted) | 137,935,873 | 84,745,116 | 73,808,237 | 65,739,844 | 64,146,848 | 46,145,563 | 45,335,927 | · | · | · | · | · | |
| EBITDA | $-22M | $25M | $-6M | $-101M | · | $-49M | $-111M | $-78M | · | · | $-33M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $38M | $17M | $194M | $206M | $192M | $188M | $248M | $178M | $105M | $60M | $64M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $197M | $77M | $127M | $0 | |
| Receivables | $2M | $3M | $3M | $36M | $790.0K | $798.0K | $13.0K | $97.0K | $10M | $2M | $372.0K | $2M | |
| Prepaid Expense | $5M | $4M | $5M | $7M | $4M | $7M | $7M | $9M | $4M | $4M | $2M | $482.0K | |
| Current Assets | $144M | $107M | $183M | $237M | $310M | $324M | $303M | $445M | $389M | $188M | $190M | $67M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $6M | $7M | $7M | $7M | $4M | $4M | $3M | $3M | |
| PP&E (Gross) | $18M | $19M | $19M | $19M | $20M | $18M | $16M | $14M | $9M | $8M | $6M | $5M | |
| Accum. Depreciation | $17M | $16M | $15M | $14M | $14M | $11M | $9M | $7M | $5M | $4M | $3M | $2M | |
| Goodwill | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Other Non-current Assets | $31.0K | $66.0K | $83.0K | $27.0K | $901.0K | $2M | $2M | $1M | $1M | $3M | $364.0K | $492.0K | |
| Total Assets | $152M | $121M | $202M | $261M | $339M | $359M | $341M | $457M | $398M | $199M | $197M | $73M | |
| Accounts Payable | $1M | $1M | $1M | $3M | $3M | $3M | $4M | $5M | $4M | $7M | $5M | $2M | |
| Accrued Liabilities | $14M | $12M | $18M | $24M | $34M | $23M | $30M | $27M | $16M | $9M | $5M | $2M | |
| Current Liabilities | $47M | $86M | $156M | $153M | $78M | $68M | $86M | $98M | $61M | $36M | $16M | $11M | |
| Capital Leases | $0 | $4M | $9M | $14M | $18M | $22M | $25M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $513.0K | $507.0K | $499.0K | |
| Other Non-current Liabilities | $4M | $4M | $4M | $0 | · | · | $850.0K | $3M | $2M | $566.0K | $198.0K | $249.0K | |
| Total Liabilities | $53M | $121M | $249M | $347M | $340M | $366M | $290M | $326M | $328M | $121M | $71M | $75M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Common Stock | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $811M | $691M | $676M | $637M | $623M | $500M | $468M | $446M | $289M | $255M | $244M | · | |
| Retained Earnings | $-712M | $-692M | $-723M | $-723M | $-624M | $-508M | $-443M | $-315M | $-219M | $-176M | $-117M | $-78M | |
| AOCI | $111.0K | $27.0K | $95.0K | $10.0K | $-242.0K | $-47.0K | $57.0K | $-93.0K | $-94.0K | $-27.0K | $-76.0K | · | |
| Stockholders' Equity | $99M | $-456.0K | $-47M | $-86M | $-459.0K | $-8M | $25M | $136M | $70M | $78M | $126M | $-79M | |
| Liabilities + Equity | $152M | $121M | $202M | $261M | $339M | $359M | $341M | $457M | $398M | $199M | $197M | $73M | |
| Shares Outstanding | 170,186,365 | 80,099,889 | 67,310,838 | 66,228,046 | 65,392,758 | 48,251,819 | 45,523,088 | 45,083,209 | 38,478,560 | 36,490,169 | 36,033,209 | 996,520 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $2M | $2M | $2M | $1M | $783.0K | |
| Stock-based Comp | $6M | $8M | $9M | $13M | $13M | $15M | $19M | $17M | $11M | $10M | $4M | $553.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | · | $-37.0K | · | $-514.0K | $-20.0K | $8.0K | $9.0K | |
| Amort. of Intangibles | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | · | · | · | |
| Operating Cash Flow | $-76M | $-86M | $-56M | $-111M | $-119M | $5M | $-140M | $-76M | $170M | $-2M | $-27M | $32M | |
| CapEx | $220.0K | $310.0K | $840.0K | $2M | $2M | $2M | $3M | $4M | $2M | $2M | $2M | $2M | |
| Investing Cash Flow | $-60M | $100M | $-151M | $98M | $22M | $-19M | $80M | $6M | $-121M | $46M | · | · | |
| Stock Issued | $110M | $7M | · | $0 | $108M | $11M | $0 | $135M | $20M | · | · | · | |
| Net Stock Activity | $110M | $7M | · | $0 | · | $11M | · | $135M | · | · | · | · | |
| Financing Cash Flow | $110M | $8M | $30M | $648.0K | $110M | $17M | $2M | $140M | $24M | $996.0K | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $73M | $45M | $-5M | $56M | |
| Taxes Paid | · | · | · | · | $0 | $0 | $13M | · | · | · | · | · | |
| Free Cash Flow | $-76M | $-87M | $-57M | $-113M | · | $3M | $-144M | $-79M | · | · | $-29M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-31M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -29.3% | 18.1% | -6.4% | -190.6% | · | -48.4% | -192.9% | -130.9% | · | · | -430.5% | · | |
| Net Margin | -22.8% | 23.1% | -0.56% | -186.8% | · | -32.8% | -177.8% | -142.2% | · | · | -458.7% | · | |
| Pretax Margin | -22.5% | 23.2% | 3.3% | -186.8% | · | -46.6% | -178.6% | -118.2% | · | · | -458.6% | · | |
| EBITDA Margin | -29.3% | 18.1% | -6.4% | -190.6% | · | -48.4% | -192.9% | -130.9% | · | · | -430.5% | · | |
| ROA | -12.8% | 19.8% | -0.25% | -33.1% | · | -9.4% | -25.6% | -19.8% | · | · | -26.2% | · | |
| ROE | -15.9% | -266.6% | 1.1% | 119.4% | · | -67.2% | -153.5% | -58.6% | · | · | -148.9% | · | |
| ROIC | -22.9% | -5443.1% | -2.3% | 118.2% | · | -68.6% | -216.1% | -71.6% | · | · | -26.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 1.3 | 1.2 | 1.6 | · | 3.2 | 3.5 | 4.5 | · | · | 12.1 | · | |
| Quick Ratio | 0.3 | 0.5 | 0.1 | 1.5 | · | 1.9 | 2.2 | 2.5 | · | · | 11.9 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -19.2 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.9 | 0.4 | 0.2 | · | 0.3 | 0.1 | 0.1 | · | · | 0.1 | · | |
| Receivables Turnover | 29.8 | 42.3 | 5.1 | 2.9 | · | 247.5 | 1045.3 | 11.6 | · | · | 5.9 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.58 | $-0.01 | $-0.70 | $-1.29 | · | $1.03 | $1.12 | $2.90 | · | · | $3.50 | · | |
| Revenue / Share | $0.55 | $1.63 | $1.37 | $0.81 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.55 | $-1.02 | $-0.76 | $-1.69 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.07 | $0.48 | $0.26 | $2.92 | · | $3.98 | $4.14 | $5.49 | · | · | $1.66 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -44.8% | 36.4% | 90.4% | 42.5% | -45.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.8% | 54.7% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.2% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $76M | $138M | $101M | $53M | $37M | $68M | $27M | $60M | $72M | $15M | $8M | · | |
| Net Income TTM | $-17M | $32M | $-569.0K | $-99M | $-116M | $-65M | $-133M | $-85M | $-43M | $-59M | $-35M | · | |
| Market Cap | $725M | $83M | $104M | $106M | · | $316M | $378M | $681M | · | · | $752M | · | |
| P/S | 9.5 | 0.6 | 1.0 | 2.0 | · | 4.6 | 14.1 | 11.4 | · | · | 97.5 | · | |
| P/B | 7.3 | -180.9 | -2.2 | -1.2 | · | 6.3 | 7.4 | 5.2 | · | · | 6.0 | · | |
| P / Tangible Book | 7.4 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -9.6 | -1.0 | -1.9 | -1.0 | · | 60.1 | -2.7 | -9.0 | · | · | -27.4 | · | |
| P / FCF | -9.6 | -1.0 | -1.8 | -0.9 | · | 107.1 | -2.6 | -8.6 | · | · | -25.9 | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $10M | $663.0K | $6M | $19M | $51M | $38M | $33M | $25M | $27M | $26M | $25M | $23M | $20M | $11M | |
| R&D Expense | $18M | $19M | $21M | $15M | $13M | $19M | $15M | $21M | $25M | $19M | $16M | $21M | $21M | $20M | $30M | |
| SG&A Expense | $8M | $11M | $7M | $6M | $7M | $9M | $6M | $8M | $8M | $8M | $7M | $7M | $8M | $10M | $10M | |
| Operating Expenses | $25M | $30M | $29M | $22M | $20M | $28M | $20M | $29M | $34M | $27M | $23M | $28M | $29M | $30M | $41M | |
| Operating Income | $-24M | $-20M | $-28M | $-16M | $-1M | $23M | $18M | $4M | $-8M | $-606.0K | $3M | $-3M | $-6M | $-10M | $-30M | |
| Interest Income | $3M | $1M | $1M | $2M | $1M | $955.0K | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $732.0K | $616.0K | |
| Other Non-op | $18.0K | $-7.0K | $-5.0K | $5.0K | $17.0K | $11.0K | $-18.0K | $-7.0K | $-2.0K | $9.0K | $-7.0K | $-47.0K | $15.0K | $1.0K | $30.0K | |
| Pretax Income | $-21M | $-18M | $-26M | $-14M | $-91.0K | $24M | $19M | $6M | $-6M | $2M | $6M | $-1M | $-3M | $-9M | $-29M | |
| Income Tax | $60.0K | $59.0K | $55.0K | $58.0K | $63.0K | $62.0K | $63.0K | $61.0K | $51.0K | $1M | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $-21M | $-18M | $-27M | $-14M | $-154.0K | $24M | $19M | $6M | $-7M | $837.0K | $3M | $-1M | $-3M | $-9M | $-29M | |
| Shares (Basic) | 218,939,423 | 177,273,000 | · | 165,004,291 | 129,075,546 | 87,121,502 | · | 85,093,227 | 84,880,632 | · | 80,731,951 | 66,536,202 | 66,248,992 | · | 65,912,334 | |
| Shares (Diluted) | 218,939,423 | 177,273,000 | · | 165,004,291 | 129,075,546 | 87,150,666 | · | 85,204,709 | 84,880,632 | · | 80,991,722 | 66,536,202 | 66,248,992 | · | 65,912,334 | |
| EBITDA | $-24M | $-20M | · | $-16M | $-1M | $23M | · | $4M | $-8M | · | $3M | $-3M | $-6M | · | $-24M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $29M | $13M | $34M | $49M | $48M | $38M | $41M | $43M | $17M | $26M | $58M | $56M | $194M | $95M | |
| Receivables | $37M | $646.0K | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $36M | $2M | |
| Prepaid Expense | $4M | $6M | $5M | $4M | $5M | $5M | $4M | $3M | $3M | $5M | $5M | $5M | $7M | $7M | $4M | |
| Current Assets | $373M | $353M | $144M | $149M | $165M | $87M | $107M | $124M | $143M | $183M | $201M | $188M | $212M | $237M | $200M | |
| PP&E (Net) | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $6M | |
| PP&E (Gross) | · | · | $18M | · | · | · | $19M | · | · | $19M | · | · | · | $19M | · | |
| Accum. Depreciation | · | · | $17M | · | · | · | $16M | · | · | $15M | · | · | · | $14M | · | |
| Goodwill | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | $949.0K | |
| Other Non-current Assets | $31.0K | $31.0K | $31.0K | $51.0K | $56.0K | $61.0K | $66.0K | $70.0K | $76.0K | $83.0K | $87.0K | $91.0K | $27.0K | $27.0K | $895.0K | |
| Total Assets | $381M | $359M | $152M | $158M | $175M | $98M | $121M | $139M | $159M | $202M | $221M | $209M | $235M | $261M | $226M | |
| Accounts Payable | $2M | $1M | $1M | $646.0K | $227.0K | $276.0K | $1M | $1M | $611.0K | $1M | $2M | $1M | $2M | $3M | $5M | |
| Accrued Liabilities | $12M | $12M | $14M | $12M | $12M | $11M | $12M | $17M | $14M | $18M | $21M | $20M | $22M | $24M | $31M | |
| Current Liabilities | $40M | $34M | $47M | $41M | $39M | $50M | $86M | $119M | $143M | $156M | $147M | $141M | $151M | $153M | $98M | |
| Capital Leases | $4M | · | $0 | $0 | $1M | $3M | $4M | $6M | $7M | $9M | $11M | $12M | $13M | $14M | $15M | |
| Other Non-current Liabilities | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $216.0K | · | $0 | · | |
| Total Liabilities | $79M | $39M | $53M | $51M | $55M | $73M | $121M | $162M | $190M | $249M | $272M | $294M | $321M | $347M | $198M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.05B | $1.05B | $811M | $790M | $788M | $693M | $691M | $687M | $685M | $676M | $673M | $642M | $640M | $637M | $634M | |
| Retained Earnings | $-751M | $-730M | $-712M | $-682M | $-668M | $-668M | $-692M | $-710M | $-716M | $-723M | $-724M | $-727M | $-726M | $-723M | $-605M | |
| AOCI | $-196.0K | $102.0K | $111.0K | $104.0K | $33.0K | $-1.0K | $27.0K | $40.0K | $-4.0K | $95.0K | $-63.0K | $35.0K | $26.0K | $10.0K | $-795.0K | |
| Stockholders' Equity | $302M | $320M | $99M | $107M | $120M | $25M | $-456.0K | $-23M | $-31M | $-47M | $-51M | $-85M | $-87M | $-86M | $28M | |
| Liabilities + Equity | $381M | $359M | $152M | $158M | $175M | $98M | $121M | $139M | $159M | $202M | $221M | $209M | $235M | $261M | $226M | |
| Shares Outstanding | · | · | 170,186,365 | · | · | · | 80,099,889 | · | · | 67,310,838 | · | · | · | 66,228,046 | 65,950,242 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $5M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $1M | $2M | $2M | $3M | $3M | |
| Amort. of Intangibles | $36.0K | $37.0K | $37.0K | $36.0K | $37.0K | $36.0K | $37.0K | $36.0K | $37.0K | $37.0K | $36.0K | $37.0K | $36.0K | $36.0K | $37.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | |
| Operating Cash Flow | $-18M | $-26M | $-23M | $-16M | $-16M | $-21M | $-20M | $-21M | $-20M | $-22M | $-18M | $-25M | $9M | $-1M | $-34M | |
| CapEx | $0 | $0 | $201.0K | $-127.0K | $27.0K | $119.0K | $80.0K | $19.0K | $96.0K | $266.0K | $9.0K | $517.0K | $48.0K | $182.0K | $410.0K | |
| Investing Cash Flow | $6M | $-193M | $-14M | $439.0K | $-76M | $31M | $15M | $18M | $22M | $13M | $-43M | $26M | $-147M | $100M | $-410.0K | |
| Stock Issued | $56.0K | $228M | $16M | $0 | $93M | $0 | $2M | $0 | · | · | $0 | · | · | · | $0 | |
| Net Stock Activity | · | $228M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $511.0K | $234M | $17M | $253.0K | $94M | $0 | $2M | $0 | $5M | $244.0K | $30M | $317.0K | $0 | $190.0K | $0 | |
| Free Cash Flow | · | $-26M | · | · | · | $-21M | · | · | · | · | · | · | $9M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1677.1% | -191.8% | · | -264.4% | -6.9% | 44.4% | · | 12.3% | -33.7% | · | 11.8% | -13.5% | -24.1% | · | -141.5% | |
| Net Margin | -1457.4% | -177.9% | · | -238.6% | -0.83% | 46.2% | · | 17.2% | -26.0% | · | 11.3% | -4.4% | -14.1% | · | -137.7% | |
| Pretax Margin | -1453.2% | -177.3% | · | -237.7% | -0.49% | 46.3% | · | 17.3% | -25.8% | · | 22.0% | · | · | · | · | |
| EBITDA Margin | -1677.1% | -191.8% | · | -264.4% | -6.9% | 44.4% | · | 12.3% | -33.7% | · | 11.8% | -13.5% | -24.1% | · | -141.5% | |
| ROA | -7.4% | -8.0% | · | -9.6% | -0.09% | 16.6% | · | 3.2% | · | · | 1.3% | -0.46% | -1.2% | · | -7.8% | |
| ROE | -9.8% | -10.6% | · | -33.9% | -0.35% | -709.6% | · | -15.4% | · | · | -26.3% | 6.0% | 35.9% | · | -33.2% | |
| ROIC | -7.9% | -6.2% | · | -14.7% | -1.8% | 90.1% | · | -17.3% | · | · | -3.1% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.4 | 10.4 | · | 3.6 | 4.2 | 1.7 | · | 1.0 | · | · | 1.4 | 1.3 | 1.4 | · | 2.0 | |
| Quick Ratio | 1.4 | 0.9 | · | 0.9 | 1.3 | 1.0 | · | 0.4 | · | · | 0.2 | 0.4 | 0.4 | · | 1.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.4 | · | 0.2 | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 0.1 | 7.9 | · | 2.4 | 8.0 | 6.7 | · | 11.6 | · | · | 12.8 | 17.0 | 22.3 | · | 13.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.43 | |
| Revenue / Share | $0.01 | $0.06 | · | $0.04 | $0.14 | $0.58 | · | $0.39 | $0.30 | · | $0.33 | $0.37 | $0.35 | · | $0.26 | |
| Cash Flow / Share | · | $-0.14 | · | · | · | $-0.24 | · | · | · | · | · | · | $0.14 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.44 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $36M | · | $114M | $141M | $148M | · | · | · | · | · | · | · | · | $21M | |
| Net Income TTM | $-80M | $-59M | · | $28M | $48M | $42M | · | · | · | · | · | · | · | · | $-125M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $96M | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 4.7 | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 3.4 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 3.5 |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $76M | $138M | $101M | $53M | $37M |
| Betriebsgewinnmarge % | -29.3% | 18.1% | -6.4% | -190.6% | · |
| Nettoergebnis | $-17M | $32M | $-569.0K | $-99M | $-116M |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.1 | 1.3 | 1.2 | 1.6 | · |
| Quick Ratio | 0.3 | 0.5 | 0.1 | 1.5 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-76M | $-87M | $-57M | $-113M | · |
Institutionelle Eigentümer (13F) 187 Einreicher · $841.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
187
Gehaltener Wert
$841.4M
Neue Positionen
48
Geschlossene Positionen
46
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 48 (-34 vs. Vorquartal) | 46 (+28 vs. Vorquartal) | 67 (+6 vs. Vorquartal) | 37 (+9 vs. Vorquartal) | +17.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $122.681.014 | 32.714.937 | 14,58% | Aktien |
| Kynam Capital Management, LP | $81.386.599 | 21.703.093 | 9,67% | Aktien |
| BlackRock, Inc. | $65.849.333 | 17.559.822 | 7,83% | Aktien |
| BANK OF AMERICA CORP /DE/ | $56.559.813 | 15.082.617 | 6,72% | Aktien |
| STATE STREET CORP | $44.052.135 | 11.747.236 | 5,24% | Aktien |
| PERCEPTIVE ADVISORS LLC | $39.146.944 | 10.439.185 | 4,65% | Aktien |
| VANGUARD GROUP INC | $36.105.988 | 8.475.584 | 4,29% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $31.970.464 | 8.525.457 | 3,80% | Aktien |
| Point72 Asset Management, L.P. | $29.291.374 | 7.811.033 | 3,48% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $19.383.605 | 5.168.961 | 2,30% | Aktien |
| Venrock Adviser, LLC | $18.682.965 | 4.982.124 | 2,22% | Aktien |
| BAKER BROS. ADVISORS LP | $18.659.348 | 4.975.826 | 2,22% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $17.548.248 | 4.678.716 | 2,09% | Aktien |
| Elmind Capital, LP | $17.062.500 | 4.550.000 | 2,03% | Aktien |
| Nextech Invest Ltd. | $16.687.245 | 4.449.932 | 1,98% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $15.497.411 | 4.132.643 | 1,84% | Aktien |
| Eversept Partners, LP | $13.344.364 | 3.558.497 | 1,59% | Aktien |
| UBS Group AG | $13.006.346 | 3.468.359 | 1,55% | Aktien |
| Siren, L.L.C. | $12.966.416 | 3.457.711 | 1,54% | Aktien |
| ADAR1 Capital Management, LLC | $12.619.193 | 3.365.118 | 1,50% | Aktien |
| CITADEL ADVISORS LLC | $11.664.409 | 3.110.509 | 1,39% | Aktien |
| MARSHALL WACE, LLP | $11.341.320 | 3.024.351 | 1,35% | Aktien |
| Woodline Partners LP | $7.650.788 | 2.040.210 | 0,91% | Aktien |
| GOLDMAN SACHS GROUP INC | $7.513.696 | 2.003.652 | 0,89% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $6.976.220 | 1.860.290 | 0,83% | Aktien |
| Qube Research & Technologies Ltd | $6.842.115 | 1.824.564 | 0,81% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.566.876 | 1.751.167 | 0,78% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $6.321.862 | 1.685.830 | 0,75% | Aktien |
| NORTHERN TRUST CORP | $6.281.937 | 1.675.183 | 0,75% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $5.177.576 | 1.380.687 | 0,62% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.752.863 | 1.267.430 | 0,56% | Aktien |
| Seven Fleet Capital Management LP | $4.070.243 | 1.085.398 | 0,48% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $3.296.250 | 879.000 | 0,39% | Aktien |
| Ally Bridge Group (NY) LLC | $2.906.250 | 775.000 | 0,35% | Aktien |
| DV EQUITIES, LLC | $2.677.500 | 714.000 | 0,32% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $2.641.586 | 704.423 | 0,31% | Aktien |
| Caption Management, LLC | $2.625.000 | 700.000 | 0,31% | Kaufoption |
| Bank of New York Mellon Corp | $2.567.022 | 684.539 | 0,31% | Aktien |
| DEUTSCHE BANK AG\ | $2.486.394 | 663.038 | 0,30% | Aktien |
| FIRST TRUST ADVISORS LP | $2.248.860 | 599.696 | 0,27% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.062.031 | 549.875 | 0,25% | Aktien |
| Ensign Peak Advisors, Inc | $1.893.956 | 505.055 | 0,23% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $1.815.833 | 484.222 | 0,22% | Aktien |
| SCHULHOFF & CO INC | $1.790.812 | 477.550 | 0,21% | Aktien |
| Exome Asset Management LLC | $1.725.251 | 460.067 | 0,21% | Aktien |
| Nuveen, LLC | $1.680.154 | 448.041 | 0,20% | Aktien |
| DAFNA Capital Management LLC | $1.644.026 | 438.407 | 0,20% | Aktien |
| Caption Management, LLC | $1.575.000 | 420.000 | 0,19% | Verkaufsoption |
| TWO SIGMA ADVISERS, LP | $1.429.332 | 335.524 | 0,17% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.395.000 | 372.000 | 0,17% | Kaufoption |
Unternehmensinsider 34 Insider · 17 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sean A. Mccarthy | CEO | 17. März 2026 S | 1.078.922 | 0 | 2 | $-1.225.921 |
| Christopher Ogden | Chief Financial Officer | 15. Juni 2026 S | 295.324 | 0 | 2 | $-129.007 |
| Carlos Campoy | Chief Financial Officer | 16. März 2023 S | 38.224 | 0 | 0 | $0 |
| Debanjan Ray | Chief Financial Officer | 25. Januar 2019 A | 5.928 | 0 | 0 | $0 |
| Ii Robert C. Goeltz | Chief Financial Officer | 12. Mai 2017 M | 32.756 | 0 | 0 | $0 |
| Alejandra Carvajal | Chief Legal Officer | 3. August 2026 A | 100.000 | 0 | 0 | $0 |
| Marcia Belvin | SVP, Chief Scientific Officer | 17. März 2026 S | 300.760 | 0 | 1 | $-202.179 |
| Yu-Waye Chu | Chief Medical Officer | 17. März 2026 S | 189.446 | 0 | 1 | $-136.611 |
| Rachael Lester | Chief Business Officer | 2. Februar 2026 A | 20.000 | 0 | 0 | $0 |
| Lloyd A Rowland | General Counsel | 18. März 2025 S | 120.594 | 0 | 0 | $0 |
| Jeffrey B Landau | Chief Business Officer | 20. August 2024 M | 119.056 | 0 | 0 | $0 |
| Amy C. Peterson | EVP, Chief Development Officer | 16. März 2023 S | 58.433 | 0 | 0 | $0 |
| Alison L. Hannah | Chief Medical Officer | 20. Juli 2022 S | 31.898 | 0 | 0 | $0 |
| Robin Knifsend | Principal Accounting Officer | 14. Februar 2020 A | 2.791 | 0 | 0 | $0 |
| William Michael Kavanaugh | CSO, Head Res.&Non-Clin. Dev. | 14. Februar 2020 A | 19.047 | 0 | 0 | $0 |
| Rachel Humphrey | Chief Medical Officer | 25. Januar 2019 A | 30.234 | 0 | 0 | $0 |
| Cynthia J Ladd | Senior VP and General Counsel | 25. Januar 2017 A | 3.000 | 0 | 0 | $0 |
| Charles S. Fuchs | Direktor | 24. Juli 2026 A | · | 0 | 0 | $0 |
| Zhen Su | Direktor | 17. Juni 2026 A | · | 0 | 0 | $0 |
| Alan Ashworth | Direktor | 17. Juni 2026 A | · | 0 | 0 | $0 |
| Mani Mohindru | Direktor | 17. Juni 2026 A | · | 0 | 0 | $0 |
| Matthew P. Young | Direktor | 17. Juni 2026 A | · | 0 | 0 | $0 |
| Halley E Gilbert | Direktor | 17. Juni 2026 A | · | 0 | 0 | $0 |
| James R Meyers | Direktor | 17. Juni 2026 A | · | 0 | 0 | $0 |
| Elaine V Jones | Direktor | 17. Juni 2026 A | 5.142 | 0 | 0 | $0 |
| Frederick W Gluck | Direktor | 15. Juni 2022 A | 237.015 | 0 | 0 | $0 |
| John A Scarlett | Direktor | 16. Juni 2021 A | · | 0 | 0 | $0 |
| Hoyoung Huh | Direktor | 13. Juni 2018 A | · | 0 | 0 | $0 |
| Marion Mccourt | Direktor | 20. Juni 2017 A | · | 0 | 0 | $0 |
| Neil Exter | Direktor | 20. Juni 2017 A | 0 | 0 | 0 | $0 |
| Timothy M Shannon | Direktor | 29. November 2016 S | 3.244.381 | 0 | 0 | $0 |
| Robert I Tepper | 10%-Eigentümer | 4. Oktober 2017 S | 29.516 | 0 | 0 | $0 |
| Kevin P Starr | 10%-Eigentümer | 12. April 2017 S | 31.419 | 0 | 0 | $0 |
| Hadley Harbor Master Investors (Cayman) L.P. | 10%-Eigentümer | 14. Oktober 2015 C | 749.055 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 35 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,69% | 103.259 NS | 31. Juli 2026 | N-PORT |
| IDNA · iShares Trust | 0,56% | 430.053 SH | 11. September 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,41% | 35.484 SH | 2. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,17% | 270.617 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,14% | 607.191 SH | 11. September 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,06% | 305.459 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,05% | 3.697 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 1.285.835 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 15.265 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 913.054 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1.024.499 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 70.221 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 104.846 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 4.590.750 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 84.673 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 146.154 SH | 2. Oktober 2026 | Täglich |
| TECB · iShares Trust | 0,01% | 17.020 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.095.997 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 484.160 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 76.464 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 5.876 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 124.826 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 16.906 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 12.796 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 59.805 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 224.287 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 1.429 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 24.102 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 71.243 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 6.230.387 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 14.861 SH | 19. August 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,00% | 282 NS | 31. Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 754.592 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 8.428 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 41.747 SH | 11. September 2026 | Täglich |
CTMX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$12.00
+368,7%
6 42,9%
Starker Kauf
7 50,0%
Kauf
1 7,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-10-02Mittelwert-Ziel $12.25 +378,5%
← Unter allen Zielen
Aktueller Preis $2.56
Tief$6.00
Mittelwert$12.25
Hoch$16.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Analysten bullish auf CytomX Therapeutics (CTMX), da CTMX eine Emission von 250 Millionen US-Dollar abschließt
Yahoo Finance · 5 Monate, 3 Wochen vor
CytomX Therapeutics (CTMX) gewinnt Analystenvertrauen durch Fortschritte in Studien
Yahoo Finance · 6 Monate vor
Jefferies erhöht das Kursziel für CytomX Therapeutics (CTMX) auf 16 $.
Yahoo Finance · 6 Monate, 1 Woche vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026